These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 15004661
1. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia. Dedic K, Zák P. Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661 [Abstract] [Full Text] [Related]
2. [Bone marrow fibrosis during therapy of hairy cell leukemia]. Dĕdic K, Zák P. Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057 [Abstract] [Full Text] [Related]
3. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment]. Urasiński I, Zdziarska B, Krygier-Stojałowska A. Acta Haematol Pol; 1996 Jan; 27(1):49-55. PubMed ID: 8629443 [Abstract] [Full Text] [Related]
4. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]. Araki H, Matsunaga T, Murase K, Kuroda H, Kuribayashi K, Terui T, Niitsu Y. Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122 [Abstract] [Full Text] [Related]
5. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J. Blood Cells Mol Dis; 1995 Jun; 21(2):142-51. PubMed ID: 8846043 [Abstract] [Full Text] [Related]
6. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine]. Zák P, Chrobák L, Dĕdic K, Podzimek K. Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629 [Abstract] [Full Text] [Related]
7. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide. Strupp C, Fenk R, Kündgen A, Gattermann N, Haas R, Germing U. Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949 [Abstract] [Full Text] [Related]
8. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. Piro LD, Carrera CJ, Carson DA, Beutler E. N Engl J Med; 1990 Apr 19; 322(16):1117-21. PubMed ID: 1969613 [Abstract] [Full Text] [Related]
9. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC. Clin Cancer Res; 1999 Jul 19; 5(7):1665-70. PubMed ID: 10430066 [Abstract] [Full Text] [Related]
19. [Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF]. Bengió R, Pérez M, Sarmiento M, Raña P, Sánchez Lucero A, Sarto A, Arrossagaray G. Medicina (B Aires); 1996 Jul 15; 56(5 Pt 1):534. PubMed ID: 9239892 [No Abstract] [Full Text] [Related]
20. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia]. Terasaki Y, Okumura H, Hirose A, Ishiura Y, Yokawa S, Saito K, Nakao S. Gan To Kagaku Ryoho; 2007 Nov 15; 34(11):1885-8. PubMed ID: 18030031 [Abstract] [Full Text] [Related] Page: [Next] [New Search]